The Clinical Impact of GLP-1 Receptor Agonists in Type 2 Diabetes: Focus on the Long-Acting Analogs
Rodbard HW
Diabetes Technology & Therapeutics. Pub. online 5 June 2018.
Leggi
Rodbard HW
Diabetes Technology & Therapeutics. Pub. online 5 June 2018.
Leggi
Cusi K, Sattar N, García-Pérez L-E, et al.
Diabetic Medicine. Pub. online 5 June 2018.
Leggi
Katerina S, Miroslav V, Martina T, et al.
Diabetes Technology & Therapeutics. Pub. online 8 June 2018.
Leggi
Garg SK, Rewers AH, Akturk HK
Diabetes Technology & Therapeutics. Pub. online 6 June 2018.
Leggi
Clemente G, Gallo M, Giorgini M; AMD – “Diabetes and Cancer” working group
Diabetes Res Clin Pract. 2018;S0168-8227(18)30519-9.
Leggi
Thorsen SU
American Journal of Epidemiology. 2018:187(6):1174-81
Leggi
Gray S, Cheetham T, McConachie H, et al.
Diabetic Medicine. Pub. online 26 May 2018
Leggi
Shin WY, Kim HC, Lee T, et al.
Diabetic Medicine. Pub. online 26 May 2018
Leggi
Picard S, Hanaire H, Reznik Y, et al.
Diabetes Technology & Therapeutics. Pub. online 30 May 2018
Leggi
Serretti A, Porcelli S
BMJ 2018;361:k2151
Leggi